Investigation Overview
April 24, 2013 (Shareholders Foundation) - An investigation on behalf of investors in PROLOR Biotech Inc (NYSEAMEX:PBTH) shares was announced concerning whether the offer by OPKO Health, Inc.to acquire PROLOR Biotech Inc for $7.00 per NYSEAMEX:PBTH share and the takeover process are unfair to investors in PROLOR Biotech shares. The investigation by a law firm concerns whether certain...
You must register (for free) or login to view the entire investigation.